ARTICLE | Politics, Policy & Law
U.K. industry group proposes fixed rebate for new pricing deal
Deal would include industry fund to invest in NHS resources, but remove cap on medicines spend
March 2, 2023 12:44 AM UTC
With major pharmas pulling out of the U.K.’s voluntary pricing agreement over concerns about the rising rebates for branded medicine sales to the NHS, the ABPI is proposing a new pricing framework that sets a fixed cost for rebates that’s paired with other incentives.
Those sweeteners could include funding to invest in NHS clinical trial and genomics capacity and a commitment that the U.K. will be a “first wave” launch country for new medicines...
BCIQ Company Profiles